Table 1 Patient clinical and pathologic characteristics
N | No. (%) | |
|---|---|---|
Age, years | 106 | 68 (58–73) a |
Gender | 106 | |
Female | 47 (44) | |
Male | 59 (56) | |
Race | 105 | |
African American | 6 (5.7) | |
Caucasian | 99 (94.3) | |
Tumor grade | 106 | |
1 | 15 (14) | |
2 | 62 (58) | |
3 | 29 (27) | |
Tumor stage | 106 | |
I-IIA | 31 (29) | |
IIB-IV | 75 (71) | |
Tumor size | 106 | 3.0 (2.1–3.5) a |
Lymph node status (N stage) | 104 | |
N0 | 35 (34) | |
N1 | 69 (66) | |
Number of resected nodes | 104 | 11.0 (8.0–18.2) a |
Number of positive nodes | 104 | 1.0 (0.0–4.0) a |
Lymph node ratio | 104 | 0.095 (0.000–0.257) a |
Operation type | 106 | |
Whipple | 93 (87.7) | |
Distal pancreatectomy | 9 (8.5) | |
Total pancreatectomy | 3 (2.8) | |
En bloc resection | 1 (1) | |
Surgical margin status | 106 | |
Negative | 75 (71) | |
Positive | 31 (29) | |
Adjuvant chemotherapy | 102 | |
No | 27 (26) | |
Yes | 75 (74) | |
Adjuvant radiation therapy | 102 | |
No | 50 (49) | |
Yes | 52 (51) | |
CA 19-9 | 106 | 157 (50–520) a |
53BP1 expression intensity | 106 | |
Low intensity | 62 (58) | |
High intensity | 44 (42) | |
Overall survival status | 106 | |
Alive | 23 (22) | |
Deceased | 83 (78) | |
Survival time, months | 106 | 15.5 (8.2–35.4) a |